|
|
 Previous Article | Table of Contents | Next Article 
In vitro expansion of human peripheral blood CD34+ cells
N Sato, K Sawada, K Koizumi, T Tarumi, M Ieko, T Yasukouchi, M Yamaguchi, TA Takahashi, S Sekiguchi and T Koike
Department of Internal Medicine II, Hokkaido University School of Medicine,
Japan.
To elucidate the role of recombinant human colony-stimulating factors
(CSFs) for expanding peripheral blood (PB) CD34+ cells, these cells were
purified up to 94.5% +/- 1.3% and the effects of individual and combined
CSFs on the proliferation and differentiation of these cells were studied
in a 7-day suspension culture. The majority of CD34+ cells coexpressed CD38
(81.8% +/- 5.1%), but was negative for CD33 (88.5% +/- 3.4%). Among the
individual CSFs examined, recombinant interleukin-3 (rIL-3) was identified
as the most potent factor for expanding PB progenitor cells and increased
nonerythroid progenitor cells 13- +/- 4- fold (P < .01). Recombinant
granulocyte-macrophage colony-stimulating factor (rGM-CSF), recombinant
granulocyte-CSF (rG-CSF), recombinant macrophage-CSF (rM-CSF), rIL-6,
rIL-11, and recombinant stem cell factor (rSCF) did not alone expand
nonerythroid progenitor cells. A combination of 5 CSFs, ie, rIL-3, rIL-6,
rGM-CSF, rG-CSF, and rSCF, was identified as the most potent combination of
those tested and increased nonerythroid progenitor cells 57- +/- 11-fold.
After a 7-day suspension culture of CD34+ cells with these 5 CSFs, CD34+
cells expanded 14.5- fold, and CD34+/CD33- cells and CD34+/CD33+ cells were
also expanded 2.9-fold and 307-fold, respectively. Most secondary colonies
derived from expanded cells were small; however, the absolute number of
large- sized colonies expanded 5.9- +/- 3.3-fold. Thus, the combination of
CSFs can achieve a degree of amplification of PB CD34+ cells. The
capability of in vitro expansion of PB CD34+ cells as an adjunct to PB stem
cell transplantation is worthy of consideration.
Volume 82,
Issue 12,
pp. 3600-3609,
12/15/1993
Copyright © 1993 by The American Society of Hematology
 CiteULike  Connotea  Del.icio.us  Digg  Reddit  Technorati What's this?
This article has been cited by other articles:
|
|
|
|
 
K. J. Way, H. Dinh, M. R. Keene, K. E. White, F. I. L. Clanchy, P. Lusby, J. Roiniotis, A. D. Cook, A. I. Cassady, D. J. Curtis, et al.
The generation and properties of human macrophage populations from hemopoietic stem cells
J. Leukoc. Biol.,
May 1, 2009;
85(5):
766 - 778.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
J. P. Chute, G. G. Muramoto, J. Fung, and C. Oxford
Soluble factors elaborated by human brain endothelial cells induce the concomitant expansion of purified human BM CD34+CD38- cells and SCID-repopulating cells
Blood,
January 15, 2005;
105(2):
576 - 583.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
H. Gur, R. Krauthgamer, A. Berrebi, T. Klein, A. Nagler, A. Tabilio, M. F. Martelli, and Y. Reisner
Tolerance induction by megadose hematopoietic progenitor cells: expansion of veto cells by short-term culture of purified human CD34+ cells
Blood,
May 13, 2002;
99(11):
4174 - 4181.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
T. Matsunaga, F. Hirayama, Y. Yonemura, R. Murray, and M. Ogawa
Negative Regulation by Interleukin-3 (IL-3) of Mouse Early B-Cell Progenitors and Stem Cells in Culture: Transduction of the Negative Signals by beta c and beta IL-3 Proteins of IL-3 Receptor and Absence of Negative Regulation by Granulocyte-Macrophage Colony-Stimulating Factor
Blood,
August 1, 1998;
92(3):
901 - 907.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
V. C. Broudy
Stem Cell Factor and Hematopoiesis
Blood,
August 15, 1997;
90(4):
1345 - 1364.
[Full Text]
[PDF]
|
|
|
|
|
|
|
X. Du and D. A. Williams
Interleukin-11: Review of Molecular, Cell Biology, and Clinical Use
Blood,
June 1, 1997;
89(11):
3897 - 3908.
[Full Text]
[PDF]
|
|
|
|
|
|
|
F. Prosper, K. Vanoverbeke, D. Stroncek, and C. M. Verfaillie
Primitive Long-Term Culture Initiating Cells (LTC-ICs) in Granulocyte Colony-Stimulating Factor Mobilized Peripheral Blood Progenitor Cells Have Similar Potential for Ex Vivo Expansion as Primitive LTC-ICs in Steady State Bone Marrow
Blood,
June 1, 1997;
89(11):
3991 - 3997.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
Y. Yonemura, H. Ku, S. D. Lyman, and M. Ogawa
In Vitro Expansion of Hematopoietic Progenitors and Maintenance of Stem Cells: Comparison Between FLT3/FLK-2 Ligand and KIT Ligand
Blood,
March 15, 1997;
89(6):
1915 - 1921.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
A. Aiuti, I.J. Webb, C. Bleul, T. Springer, and J.C. Gutierrez-Ramos
The Chemokine SDF-1 Is a Chemoattractant for Human CD34+ Hematopoietic Progenitor Cells and Provides a New Mechanism to Explain the Mobilization of CD34+ Progenitors to Peripheral Blood
J. Exp. Med.,
January 6, 1997;
185(1):
111 - 120.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
K. N. M. Khan, A. A. Kats, M. M. Fouant, S. S. Snook, J. P. Mckearn, C. L. Alden, and P. F. Smith
Recombinant Human Interleukin-3 Induces Extramedullary Hematopoiesis at Subcutaneous Injection Sites in Cynomolgus Monkeys
Toxicol Pathol,
July 1, 1996;
24(4):
391 - 397.
[Abstract]
[PDF]
|
|
|
|
|
|
|
A. Berardi, A Wang, J. Levine, P Lopez, and D. Scadden
Functional isolation and characterization of human hematopoietic stem cells
Science,
January 6, 1995;
267(5194):
104 - 108.
[Abstract]
[PDF]
|
|
|
|
|
|
|
T Mahdi, A Brizard, C Millet, P Dore, J Tanzer, and A Kitzis
In vitro p53 and/or Rb antisense oligonucleotide treatment in association with growth factors induces the proliferation of peripheral hematopoietic progenitors
J. Cell Sci.,
January 3, 1995;
108(3):
1287 - 1293.
[Abstract]
[PDF]
|
|
|
|
|
